Drugs / Natural killer
last change Jul 2019 re-read 3 minutes ago

Natural killer

Developed for
liver cancer
Investigated by
Fuda Cancer Hospital, Guangzhou · Shenzhen Hank Bioengineering Institute

Trials 1

20172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT03008343 Dec 2016 → Dec 2017 liver cancer Fuda Cancer Hospital, Guangzhou Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Natural killer ClinicalTrials.gov intervention name — accepted as the source's own label NCT03008343 ↗
Route Intravenous “transfuion in 3 times, i.v.” NCT03008343 ↗